Overview

Gender

male

Dirk is an MD, PhD with 12+ years of Pharma Industry experience in oncology drug development from global leadership positions (Merck, Novartis, Takeda). He has worked in early- and late-stage clinical development programs which included interactions with all major regulatory authorities, dossier filing and successful lead of submission teams. He also has extensive experience in conducting Medical Affairs activities to prepare markets for commercial launches. He has longstanding oncology drug development expertise with major brands (Afinitor, Patupilone, Sandostatin, Erbitux, Matuzumab, Adcetris, Ixazomib, Alisertib, Mepact). He has excellent regulatory filing and launch experience throughout career. His extended leadership experience he gained by leading clinical teams at Merck and Novartis as well as by leading the EM regional office of Takeda Oncology as Medical Director with managing the medical strategy of the oncology portfolio in 30+ Emerging Market countries. He is co-founder of Aurealis Pharma and Cellestia Biotech SA and represents both companies as Chief Medical Officer.